Reddy Abhinav V, Mills Matthew N, Liauw Stanley L, Baliga Sujith, Kersh Charles R
Transitional Year Program, Riverside Regional Medical Center, Newport News, Virginia, USA.
Can J Urol. 2019 Apr;26(2):9743-9745.
Renal cell carcinoma (RCC) is usually treated with surgery, with or without systemic therapy. For select patients, stereotactic body radiation therapy (SBRT) may be a suitable alternative. Although many reports exist on the successful use of SBRT, very few have described long term outcomes with regard to disease progression and renal function. We report a rare case of a single patient with primary, metastatic, and locally recurrent renal cell carcinoma who was successfully treated with SBRT. The patient has been disease-free for 8 years since treatment, with stable renal function even after two courses of SBRT to her solitary functioning kidney.
肾细胞癌（RCC）通常采用手术治疗，可联合或不联合全身治疗。对于部分患者，立体定向体部放射治疗（SBRT）可能是一种合适的替代治疗方法。虽然有许多关于成功使用SBRT的报道，但很少有描述疾病进展和肾功能方面的长期结果。我们报告了一例罕见病例，一名原发性、转移性和局部复发性肾细胞癌患者成功接受了SBRT治疗。自治疗以来，该患者已无病生存8年，即使在对其孤立的功能肾进行两疗程SBRT后，肾功能仍保持稳定。
